Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals

dc.contributor.authorAiello, Tommaso Francesco
dc.contributor.authorPuerta-Alcalde, Pedro
dc.contributor.authorChumbita, Mariana
dc.contributor.authorLopera, Carlos
dc.contributor.authorMonzó Gallo, Patricia
dc.contributor.authorCortes, Albert
dc.contributor.authorFernández Avilés, Francesc
dc.contributor.authorSuárez-Lledó Grande, María
dc.contributor.authorCorrea, Juan
dc.contributor.authorOrtiz-Maldonado Gibson, Valentín
dc.contributor.authorCuesta, Genoveva
dc.contributor.authorMartínez Cibrian, Nuria
dc.contributor.authorEsteve Reyner, Jordi
dc.contributor.authorMarcos, María Ángeles
dc.contributor.authorMensa, Josep
dc.contributor.authorSoriano Viladomiu, Alex
dc.contributor.authorGarcia Vidal, Carolina
dc.date.accessioned2024-01-24T13:20:10Z
dc.date.available2024-04-13T05:10:15Z
dc.date.issued2023-04-13
dc.date.updated2024-01-18T08:30:26Z
dc.format.extent17 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idimarina9349946
dc.identifier.issn1460-2091
dc.identifier.pmid37051877
dc.identifier.urihttps://hdl.handle.net/2445/206271
dc.language.isoengca
dc.publisherOxford University Pressca
dc.relation.isformatofVerisó postprint del document publicat a: https://doi.org/10.1093/jac/dkad105
dc.relation.ispartofJournal Of Antimicrobial Chemotherapy, 2023, vol. 78, num. 6, p. 1454-1459
dc.relation.urihttps://doi.org/10.1093/jac/dkad105
dc.rights(c) Oxford University Press, 2023
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
dc.subject.classificationMedicaments antivírics
dc.subject.classificationMedicaments dermatològics
dc.subject.otherAntiviral agents
dc.subject.otherDermatologic agents
dc.titleCurrent outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antiviralsca
dc.typeinfo:eu-repo/semantics/articleca
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
Early antiviral in hemato Covid.pdf
Mida:
387.08 KB
Format:
Adobe Portable Document Format